With growing fossil fuel prices and energy security concerns, the global power crisis is growing severely and encouraging the world to fasten the development towards renewable energy sources such as solar, wind, and hydro. According to a report by International Energy Agency (IEA), solar energy is ready to record the largest annual growth in new renewable energy capacity ever. Global renewable capacity additions are set to soar by 107 gigawatts (GW), the largest absolute increase ever, to more than 440 GW in 2023.The report also suggested that the contribution of solar energy was the highest in this gigantic growth of the renewable energy industry. To support the argument the data presented by IEA suggested that Solar PV’s power capacity is expected to surpass that of coal by 2027, beco...

AI and Its Intervention in Global MarketArtificial Intelligence (AI) is one of the most discussed revolutions of the current global scenario. It is bringing big changes in every industry all around the world. AI with new technologies, regular updates and consistent innovation is helping industries to break all the conventional working processes and bringing more accuracy and credibility to the global market. There is no industry which has been left untouched by the intervention of AI in the global market and one of the most talked about in them is Healthcare Industry. With the help of AI not just big innovations are being experienced in healthcare but also day-to-day health check has been possible because of the technology like Smart Watch and Fit-Band,AI Disrupting Healthcare and Chang...

On June 28, 2023, Pfizer Inc. and OPKO Inc. announced that their growth hormone NGENLA (somatrogon-ghla) has finally been approved by the US Food and Drugs Administration (FDA) for a once-a-week dosage to treat pediatric Growth Hormone Deficiency (GHD). Last year, the FDA approved NGENLA for marketing, however, they did not provide approval for usage.Developed as a part of the Next Generation of Long-Acting Growth Hormone (LAGH), NGENLA is a human growth hormone analogue that is presented by the partnership of Pfizer Inc. and OPKO Inc. to treat GHD in pediatric patients of ages 3 and above. This LAGH can be administered once a week as a subcutaneous injection to pediatric patients of ages 3 and above that are suffering from GHD. Compared to Pfizer’s previous once-daily growth hormone GE...

On June 15, 2023, Roche’s independent subsidiary and biotechnology company – Genentech, announced that their bispecific antibody Columvi (glofitamab-gxbm) has been given accelerated approval by The US Food and Drugs Administration (FDA). This accelerated approval is a result of the positive results that Columvi demonstrated in clinical trials in patients with relapsed or refractory (R/R) diffuse large B cell Lymphoma (DLBCL). These patients received fixed-duration administration of Columvi and durable remission was observed in them, with a chance of complete remission. Explore quality insights into the Global Non-Hodgkin Lymphoma Treatment Market and learn about the emerging trends, market size, major players, and the latest FDA approvals. Find more quality information on this by access...

On July 17, 2023, it was announced by the U.S. Food and Drug Association have approved Sanofi and AstraZeneca’s jointly developed medicine Beyfortus (nirsevimab-alip) for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in newborns and infants.RSV is a virus that affects people of all ages, causing short-term respiratory infections in them. RSV usually only brings mild symptoms such as cold and cough in most infants and children. However, it has been shown to be more harmful to some infants – causing lower respiratory tract disease in them, which might require hospitalization. This is especially true for infants dealing with their first infection. They might develop lower respiratory tract diseases such as bronchiolitis and pneumonia – which can be cri...

On June 27, 2023, UCB - A multinational biopharmaceutical company based in Belgium announced that their Rystiggo (rozanolixizumab-noli) has been approved by The US Food and Drug Administration (FDA) for the treatment of adult patients with Generalized Myasthenia Gravis (gMG) who are positive in the antibody anti-muscle-specific tyrosine kinase (MuSK) or anti-acetylcholine receptor (AChR).gMG is a progressive autoimmune disease that impacts the neuromuscular system of the body. The symptoms vary greatly for each patient, and hence there is no cure for this disease so far. However, clinical trials and history have indicated that several different types of treatments can help reduce the symptoms in gMG and help remission. The latest addition to treatment options is the FDA-approved Rystigg...

On July 20, 2023, Daiichi Sankyo Company, Limited – a global pharmaceutical giant, announced that for the treatment of adults with newly diagnosed FLT3 - ITD Positive Acute Myeloid Leukemia (AML) - an inhibitor, VANFLYTA (Quizartinib), has been approved by The US Food and Drugs Association in combination with anthracycline induction, standard cytarabine, and cytarabine consolidation, and as maintenance monotherapy following consolidation chemotherapy. The FLT3 - ITD mutation is present in around 37% of patients with AML, which is a common Leukemia form in adults. This mutation contributes to cancer growth and reduces the survival rate of patients. However, the approval of Daiichi Sankyo’s VANFLYTA is a sign of advancement in the treatment of patients with the mutation.“The approval of V...

Agriculture is one of the most crucial industries for the economic growth of the world contributing 4% of the world's total GDP. Many developing and underdeveloped countries are dependent on the revenue that comes from agriculture and it can be accounted for more than 25% of their GDP (WorldBank.org, 2023). According to the OECD.org, agricultural trade is growing rapidly and has increased by 7% annually between 2001-2019. Trade of agricultural products has not just been restricted to national boundaries since COVID-19 and going global. This generates the need for custom research in the agriculture industry to move towards smart transformation for growth and sustainability.Smart Transformation of the Global Agriculture IndustryA report by OMR presented that is agriculture industry global...

The semiconductor market globally is seeing an increase in sales and revenue due to increasing demand for semiconductor supplies by different industries. According to research by OMR, the Semiconductor market is forecast to grow by 7% in 2023-30. Every sector such as electronics, information and communication, automotive and many more to improve performance and productivity requires semiconductors. Various research has shown that technologies like AI, IoT and Big Data are using semiconductors to improve the profitability, productivity and performance of the product. Automotive Industry is benefitting immensely while integrating with the semiconductor market.Automotive Semiconductor for New ICE Age VehiclesSemiconductor in the automotive industry has been used widely for different purpos...

Due to rising respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) and other health issues due to dry air, the trend of using air humidifiers in the market has drastically increased in the past several years. The market of global air humidifiers is forecasted to record growth of a CAGR of 5.0% by 2031.Since marketing is growing and expected to grow further rapidly, new trends and technologies are being used to grow the market higher with the right integration of technologies. Some major players in the global air humidifier market are Honeywell International Inc., Koninklijke Philips N.V., Mitsubishi Heavy Industries, Ltd. and more. Many new entrants are entering the market with new-age technologies and upgradation making the market more competitive. So le...